Skip to content

Characterizing and Comparing the Profile of Microorganisms From Specific Body Sites and Environmental Surfaces in Newly Disinfected Patient Rooms

Study of the Temporal Profile and Bi-directional Transmission of Microorganisms Between Patients and Environmental Surfaces.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01803100
Enrollment
80
Registered
2013-03-04
Start date
2013-01-31
Completion date
2015-10-31
Last updated
2015-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Infection

Keywords

Bacterial Colonization

Brief summary

Overall Aim: To describe and to assess the change in the temporal profile and transmission of microorganisms between patients and environmental surfaces after admission into a newly disinfected room. Study Activities: Investigators will prospectively and concurrently perform microbiological sampling of body sites (nose, throat, axillae, perineal and wounds) high touch surfaces (e.g. bedside rail, bed surface, toilet seat, IV pump and tray table) for consented adult patients admitted to freshly cleaned patient rooms. The microbiological sampling of body sites is already performed in many units of the hospital as standard of care. Infection and readmission related data from enrolled patients will be collected for upto 1 year after enrollment. Data analysis: Standard surveillance for hospital-acquired infections will be performed by the infection control group of the hospital. The identity and the nature of micro-organisms colonizing the high touch surfaces of rooms and of patient's body sites will be determined and compared. Risks involved is no more than minimal risk.

Interventions

OTHERNo intervention

There is no intervention in this trial

Sponsors

University of North Carolina, Chapel Hill
CollaboratorOTHER
Durham VA Medical Center
CollaboratorFED
Duke University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Eligible patients who provide informed consent.

Exclusion criteria

* Pediatric patients under 18 years of age, * Patients who cannot or do not provide consent

Design outcomes

Primary

MeasureTime frame
Changes in the Profile of Epidemiologically-Important OrganismDay 3, 7 and each week after enrollment

Secondary

MeasureTime frame
Time to Change in the Profile of Epidemiologically Important OrganismDay 3, 7 and each week after enrollment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026